Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION

(DHR)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Danaher Corporation : Danaher CEO Comments on Outlook

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/08/2013 | 09:38pm EDT

Washington, D.C., January 8, 2013 - Danaher Corporation (NYSE:DHR) announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company's performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company's fourth quarter 2012 diluted net earnings per share is anticipated to be above the high end of the previously announced range of $0.80-0.85, with higher than expected core revenue growth in the quarter.

Mr. Culp stated: "We are pleased by the strong finish to the year from both a revenue and earnings perspective, which was broad-based across most of our businesses."

As previously announced, the company will hold its quarterly earnings conference call for the fourth quarter and year-end 2012 on Tuesday, January 29, 2013 at 8:00 a.m. EST.

* * *

Danaher is a science and technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers.  Our premier brands are among the most highly recognized in each of the markets we serve.  The Danaher Business System provides a foundation to our 59,000 associates around the world, serving customers in more than 125 countries.  In 2011, we generated $16.1 billion of revenue.  For more information please visit our website: www.danaher.com.

Statements in this release that are not strictly historical, including the statements regarding the Company's anticipated diluted net earnings per share and core revenue growth for the fourth quarter 2012 and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, are "forward-looking" statements within the meaning of the federal securities laws.  There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, deterioration of or instability in the economy and financial markets, the impact of our restructuring activities on our ability to grow, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conduct by our employees, agents or business partners, our ability to successfully identify, consummate and integrate appropriate acquisitions (including our ability to effectively integrate the Beckman Coulter acquisition and realize the anticipated benefits therefrom), contingent liabilities relating to acquisitions (including our acquisition of Beckman Coulter) and divestures, our compliance with applicable laws and regulations (including regulations relating to medical devices and the healthcare industry) and changes in applicable laws and regulations, our ability to effectively address cost reduction and other changes in the healthcare industry, risks relating to potential impairment of goodwill and other long-lived assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, litigation and other contingent liabilities including intellectual property and environmental matters, risks relating to product defects and recalls, the impact of our debt obligations on our operations, our relationships with and the performance of our channel partners, commodity costs and surcharges, our ability to adjust purchases and  manufacturing capacity to reflect market conditions, labor matters,  international economic, political, legal and business factors, risks relating to man-made and natural disasters, pension plan costs and our non-controlling interest in the Apex joint venture.  Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2011 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the third quarter of 2012. These forward-looking statements speak only as of the date of this release and the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

Please contact:

Matt McGrew
Vice President, Investor Relations
Danaher Corporation
2200 Pennsylvania Avenue, NW
Suite 800W
Washington, D.C. 20037
Telephone: (202) 828-0850
Fax: (202) 828-0860


HUG#1669168


distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER CORPORATION
03/19DANAHER : Schedules First Quarter 2019 Earnings Conference Call
PR
03/14GENERAL ELECTRIC : 2019 Adjusted EPS Forecast Below Street Views
DJ
03/11DANAHER : Announces quarterly dividend
AQ
03/08DANAHER : Announces Quarterly Dividend
PR
03/07GENERAL ELECTRIC : GE Lures New Batch of Investors
DJ
03/06GENERAL ELECTRIC : The Investors Who Bet on GE and Won
DJ
03/01DANAHER CORP /DE/ : Material Modification to Rights of Security Holders, Amendme..
AQ
03/01DANAHER : Announces Closing Of Common Stock Offering And Mandatory Convertible P..
PR
02/27DANAHER : Announces Pricing Of Common Stock Offering And Mandatory Convertible P..
PR
02/26GENERAL ELECTRIC : GE sells biopharma unit for $21 billion
AQ
More news
Financials ($)
Sales 2019 20 504 M
EBIT 2019 4 370 M
Net income 2019 2 865 M
Debt 2019 5 797 M
Yield 2019 0,53%
P/E ratio 2019 32,56
P/E ratio 2020 29,32
EV / Sales 2019 4,79x
EV / Sales 2020 4,40x
Capitalization 92 403 M
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Average target price 133 $
Spread / Average Target 2,7%
EPS Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Steven M. Rales Chairman
Matthew R. McGrew Chief Financial Officer
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER CORPORATION25.77%92 403
THERMO FISHER SCIENTIFIC17.88%108 150
INTUITIVE SURGICAL17.19%66 677
BOSTON SCIENTIFIC CORPORATION5.55%52 874
ILLUMINA2.95%46 924
SIEMENS HEALTHINEERS AG2.61%43 579